Corvus Pharmaceuticals, Inc.

TEMA ETFS LLC CRVS
Report date
3/31/2026
Quarter
2026 Q1
Filed
4/15/2026
Shares
107,775
Value ($000)
1,577
Weight
0.1%
2025 Q3 - 2026 Q1 (3 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).